COMMUNIQUÉS West-GlobeNewswire

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
26/01/2026
Daix (France), New York City (New York, Etats-Unis), le 26 janvier 2026 – Inventiva (Euronext Paris and Nasdaq: IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement de thérapies orales pour [...]
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
26/01/2026
Daix (France), New York City (New York, United States), January 26, 2026 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
26/01/2026
WATERTOWN, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City
26/01/2026
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in [...]
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast
26/01/2026
GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
26/01/2026
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
HNL Lab Medicine Employees Select Local Charities for Annual Donation
26/01/2026
ALLENTOWN, Pa., Jan. 26, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine continues its tradition of community giving by empowering employees to nominate nonprofit organizations that hold personal meaning to them. Through this [...]
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
26/01/2026
SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after [...]
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
27/01/2026
NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on use of Ryoncil ® (remestemcel-L [...]
Hapbee Appoints Marketing Expert Bally Singh to Board of Directors to Spearhead Global Brand Evolution
26/01/2026
Strategic move aligns with record $6.8 trillion global wellness market surge - forecasted to hit $9.8 trillion by 2029 - and drives major company-wide rebrand VANCOUVER, British Columbia, Jan. 26, 2026 (GLOBE NEWSWIRE [...]
Da Vinci 5 Cleared for Cardiac Procedures
26/01/2026
FDA 510(k) clearance expands da Vinci 5 indications to include certain cardiac procedures SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive [...]
Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
26/01/2026
ELPIS II top-line trial results are anticipated in the third quarter of 2026 Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS anticipated if ELPIS II results are [...]
DoseSpot's pVerify Achieves Multiple 2025 Recognitions from Gartner Digital Markets' Capterra, Software Advice and GetApp
26/01/2026
BOSTON, Jan. 26, 2026 (GLOBE NEWSWIRE) -- DoseSpot , which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today that its pVerify [...]
Quantum Brainwave Protocol Product Information Updated as Consumer Interest in Digital Audio Relaxation Programs Grows in 2026
26/01/2026
An informational overview examining category context, publicly available product disclosures, and what consumers often consider when researching digital audio relaxation programs New York, NY, Jan. 26, 2026 (GLOBE [...]
Purely Me Skin Tag Remover Product Information Updated as Consumer Interest in At-Home Skin Tag Solutions Grows in 2026
26/01/2026
An informational overview examining category context, publicly available product disclosures, and what consumers often consider when researching non-prescription skin tag products New York, NY, Jan. 26, 2026 (GLOBE [...]
Health-ISAC 2026 Report Details Rising Cyber Threats Across Health Sector
26/01/2026
Report highlights rising ransomware attacks, third-party vulnerabilities, and evolving social engineering tactics shaping health sector security ORLANDO, Fla., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Health-ISAC today [...]
Indivior Announces Completion of Redomiciliation to the United States
26/01/2026
RICHMOND, Va., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), today announced completion of its redomiciliation from the United Kingdom to the United States. As a result, Indivior [...]
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology
26/01/2026
National broadcast highlights the need for new approaches in one of the deadliest forms of cancer HOUSTON, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology [...]
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
26/01/2026
BURLINGTON, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system [...]

Pages